RSC acquires rights to Merck Index


The Royal Society of Chemistry (RSC) has acquired the rights to the ‘bible’ of chemistry, the Merck Index, familiar around the world to medicinal chemists and drug discovery scientists. The society will be responsible for publishing the 15th edition of the iconic red tome, which bills itself as ‘chemistry’s constant companion’. The organisation also has plans to make the index more accessible and expand its online presence.

To date, the Merck Index has sold more than 1 million copies around the world over its 123-year lifespan. The index contains a whole host of chemical structures and information on small molecule and biological drugs, environmentally important compounds and industrial and speciality chemicals, for example. The current edition also contains more than 10,000 monographs and 450 named organic reactions.

‘We are very excited to be welcoming a title as prestigious as the Merck Index to the RSC portfolio,’ said James Milne, RSC publishing executive director. ‘It makes an excellent strategic fit with our current publishing activities, complementing existing services such as ChemSpider, the award-winning free database of chemical structures.’

Derek Lowe, a medicinal chemist and regular columnist for Chemistry World, says that he thinks the RSC has got the right idea by expanding the index’s online offering. However, he notes that any upgraded index will be battling against other online sources, such as Wikipedia, and will have to work hard to make a name for itself on the internet.


Related Content

End of the road for h-index rankings

27 November 2012 News and Analysis

news image

Criticism leads US group to stop collating ranked list of living chemists

Amid huge cuts, Merck vows research focus

4 October 2013 Business

news image

8500 more jobs to be axed, but the drugmaker ‘remains committed to innovation’

Most Read

Bubble wrap could send lab costs packing

23 July 2014 Research

news image

Potential bubbles up across wide range of uses as storage and test vessels, especially for poor countries

Takeover battle pushes Allergan to cut R&D jobs

28 July 2014 Business

news image

Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth

Most Commented

Bubble wrap could send lab costs packing

23 July 2014 Research

news image

Potential bubbles up across wide range of uses as storage and test vessels, especially for poor countries

Relativity behind mercury's liquidity

21 June 2013 Research

news image

First evidence that relativistic effects are indeed responsible for mercury's low melting point